Table 1.

Studies examining the impact of aging on plasma VWF levels in type 1 VWD cohorts

StudynBaseline plasma VWF levelsAge at diagnosis (range), yDuration of follow-up, mean (range), yBaseline plasma VWF levels, mean, IU/dLChange in plasma VWF levels, IU/dL/yLast plasma VWF level >50 IU/dL, n (%)
<30 IU/dL30-50 IU/dL
Abou-Ismail et al34  126 46 80 Mean 27.7 ± 16.2 (SD) 10.5 (5-20) VWF:Ag 40.6
VWF:RCo 36.7 
VWF:Ag 2.4
VWF:RCo 1.4 
35/126 (27.8) 
Borghi et al26  195 52  Median 28.7 (0.4-74.5) 6.6 (0.4-24.7) VWF:Ag 23
VWF:RCo 18 
VWF:Ag 0.62 VWF:RCo 0.47 117/195 (60) 
 143 VWF:Ag 47
VWF:RCo 43 
Lavin et al.25  64 64 Mean 36.4 (15-66) 8.5 (5-17) VWF:Ag 47.8
VWF:RCo 39.4 
VWF:Ag 1.9 VWF:RCo 1.5 29/64 (45) 
Rydz et al33  31 23 Mean 30 (16-60) 11 (5-26) VWF:Ag 44
VWF:RCo 34 
VWF:Ag 3.0
VWF:RCo 2.0 
18/31 (58) 
Sanders et al24  40 40  Only age at study inclusion reported  VWF:Ag 0.35
VWF:RCo 0.95 
 
StudynBaseline plasma VWF levelsAge at diagnosis (range), yDuration of follow-up, mean (range), yBaseline plasma VWF levels, mean, IU/dLChange in plasma VWF levels, IU/dL/yLast plasma VWF level >50 IU/dL, n (%)
<30 IU/dL30-50 IU/dL
Abou-Ismail et al34  126 46 80 Mean 27.7 ± 16.2 (SD) 10.5 (5-20) VWF:Ag 40.6
VWF:RCo 36.7 
VWF:Ag 2.4
VWF:RCo 1.4 
35/126 (27.8) 
Borghi et al26  195 52  Median 28.7 (0.4-74.5) 6.6 (0.4-24.7) VWF:Ag 23
VWF:RCo 18 
VWF:Ag 0.62 VWF:RCo 0.47 117/195 (60) 
 143 VWF:Ag 47
VWF:RCo 43 
Lavin et al.25  64 64 Mean 36.4 (15-66) 8.5 (5-17) VWF:Ag 47.8
VWF:RCo 39.4 
VWF:Ag 1.9 VWF:RCo 1.5 29/64 (45) 
Rydz et al33  31 23 Mean 30 (16-60) 11 (5-26) VWF:Ag 44
VWF:RCo 34 
VWF:Ag 3.0
VWF:RCo 2.0 
18/31 (58) 
Sanders et al24  40 40  Only age at study inclusion reported  VWF:Ag 0.35
VWF:RCo 0.95 
 
Close Modal

or Create an Account

Close Modal
Close Modal